Sentence examples for routine coagulation assay from inspiring English sources

However, three components of the routine coagulation assay, including bleeding time, prothrombin time and platelet count, could be modeled to show prolonged postoperative hypercoagulability (P < 0.01).

However, three components of the routine coagulation assay, including the bleeding time, prothrombin time and platelet count, could be modeled to show prolonged postoperative hypercoagulability (P < 0.01).

However, three components of the routine coagulation assay, including the bleeding time, prothrombin time, and platelet count, could be modeled to show prolonged postoperative hyper-coagulability (P < 0.01).

Deficiencies in these proteins are often undiagnosed for decades and detected later in life during routine coagulation assays without an apparent clinical phenotype.

NOACs affect all routine coagulation assays [ 72].

The decrease in procoagulant proteins is evidenced by prolonged test results of routine coagulation assays such as the prothrombin time (PT) and activated partial thromboplastin time (APTT).

In one study in 118 healthy blood donors [ 35] the authors found that 18.6% of the donors had at least one abnormal TEG parameter according to the manufacturer's reference values, with the greatest differences involving the R (reaction time), alpha (clot strengthening) and MA (clot strength) parameters, even if none of the volunteers had abnormal routine coagulation assays.

Calculation of the score requires only routine coagulation tests: platelets count, assay of a fibrin-related marker, prothrombin time and fibrinogen.

It is critically important to recognize that the routine coagulation tests, such as platelet count, global clotting assays, and measurement of coagulation factors, might miss clinically significant coagulation defects that can contribute to bleeding.

FIX coagulant activity was assessed by the aPTT coagulation assay (48).

Although the obviation of the need for routine monitoring is welcome both from practical and from health care expenditure perspective, the availability of a reliable coagulation assay can be of help to estimate the intensity of anticoagulation in specific situations, such as potential drug drug interactions, reduced hepatic and/or renal function, and elderly patients.